Metrics as of 10/16/2026, 11:58 PM (Berlin time), refresh in progress.
Centene Corp.
Centene Corp. operates as a managed care company that provides programs and services to under-insured families and commercial organizations in the United States. The company was founded in 1984 and is headquartered in St. Louis, Missouri. Centene Corp. operates through four segments, including the Medicaid segment…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-1.9%
1W
+5.8%
1M
+4.8%
6M
+81.2%
YTD
+68.1%
1Y
+94.1%
2Y
-0.2%
5Y
+5.9%
10Y
+130.3%
Next earnings date
27/10/2026 (in 10 days)
Volatility around earnings
~21% stronger price swings than usual
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
Centene Corporation is a specialized managed care company that provides health care services and insurance programs to low-income families and commercial organizations in the United States. A key focus is the Medicaid segment, which contributes 75.8 percent to revenue and includes programs for disadvantaged individuals as well as support for seniors and people with disabilities. The portfolio is complemented by Medicare offerings, private health insurance in the commercial sector, and clinical services such as pharmacy and specialized medical care.
PRICE TARGET LOW
US$39.00
CONSENSUS
US$68.29
MEDIAN
US$70.00
PRICE TARGET HIGH
US$80.00
0
STRONG BUY
27
BUY
16
HOLD
1
SELL
0
STRONG SELL
44
TOTAL · Buy
As of: 11/08/2026
P/E
-6.65
P/B
1.51
EV/EBITDA
-9.56
RETURN ON EQUITY
4.8%
NET MARGIN
2.5%
DEBT/EQUITY
0.71
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
98.2%
FLOAT SHARES
485,182,129
AVG. DAILY VOLUME (30D)
4,553,499
Carson Michael A
Tyler Lauren M
TANJI KENNETH
COUGHLIN CHRISTOPHER J
Samuels Theodore R. II
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.9%
Forums (Reddit)
Register for free
Register now to see which funds are invested
Centene Corp. is a company in the Healthcare sector, Medical - Healthcare Plans industry, headquartered in United States.
The CEO is Sarah McGinty London, the company employs around 61,100 people.
The IPO was on 13/12/2001; the stock trades on NYSE under the ticker CNC.
44 analysts rate the stock, the consensus is Buy (as of 11/08/2026).
The average price target is US$68.29, ranging from US$39.00 to US$80.00, with a median of US$70.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 27/10/2026.
Around past earnings, price swings were roughly 21% stronger than usual.
No, Centene currently does not pay a dividend.
Comparable stocks include UnitedHealth Group, CVS Health, Elevance Health, Cigna, Humana, Molina Healthcare and Oscar Health.
Clicking "Analyze stock" lets five strategies assess Centene against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.